IPRIPR2023-00739Terminated-Adverse Judgment
Samsung Bioepis Co., Ltd.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 10888601.
Type
IPR
Filed
Mar 26, 2023
Instituted
Oct 20, 2023
Decided
Jul 30, 2024
Patent
Application
16397267
Inventor
George D. YANCOPOULOS
Granted
Jan 12, 2021
01
Timeline
3 milestones
2023-03-26Petition filed
2023-10-20Institution
2024-07-30Terminated
02
Parties & counsel
Petitioner
Samsung Bioepis Co., Ltd.
Counsel
Nimrod, Raymondet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Brausa, Adamet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →